Here's how BMCCANCER.BIOMEDCENTRAL.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

BMCCANCER . BIOMEDCENTRAL . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Bmccancer.biomedcentral.com Make Money
  6. How Much Does Bmccancer.biomedcentral.com Make
  7. Keywords
  8. Topics
  9. Schema
  10. Social Networks
  11. External Links
  12. Analytics And Tracking
  13. Libraries
  14. CDN Services

We are analyzing https://bmccancer.biomedcentral.com/articles/10.1186/1471-2407-12-124.

Title:
Report on emerging technologies for translational bioinformatics: a symposium on gene expression profiling for archival tissues | BMC Cancer | Full Text
Description:
Background With over 20 million formalin-fixed, paraffin-embedded (FFPE) tissue samples archived each year in the United States alone, archival tissues remain a vast and under-utilized resource in the genomic study of cancer. Technologies have recently been introduced for whole-transcriptome amplification and microarray analysis of degraded mRNA fragments from FFPE samples, and studies of these platforms have only recently begun to enter the published literature. Results The Emerging Technologies for Translational Bioinformatics symposium on gene expression profiling for archival tissues featured presentations of two large-scale FFPE expression profiling studies (each involving over 1,000 samples), overviews of several smaller studies, and representatives from three leading companies in the field (Illumina, Affymetrix, and NuGEN). The meeting highlighted challenges in the analysis of expression data from archival tissues and strategies being developed to overcome them. In particular, speakers reported higher rates of clinical sample failure (from 10% to 70%) than are typical for fresh-frozen tissues, as well as more frequent probe failure for individual samples. The symposium program is available at http://www.hsph.harvard.edu/ffpe . Conclusions Multiple solutions now exist for whole-genome expression profiling of FFPE tissues, including both microarray- and sequencing-based platforms. Several studies have reported their successful application, but substantial challenges and risks still exist. Symposium speakers presented novel methodology for analysis of FFPE expression data and suggestions for improving data recovery and quality assessment in pre-analytical stages. Research presentations emphasized the need for careful study design, including the use of pilot studies, replication, and randomization of samples among batches, as well as careful attention to data quality control. Regardless of any limitations in quantitave transcriptomics for FFPE tissues, they are often the only biospecimens available for large patient populations with long-term history and clinical follow-up. Current challenges can be expected to remain as RNA sequencing matures, and they will thus motivate ongoing research efforts into noise reduction and identification of robust, translationally relevant biological signals in expression data from FFPE tissues.
Website Age:
25 years and 10 months (reg. 1999-08-06).

Matching Content Categories {๐Ÿ“š}

  • Education
  • Science
  • Careers

Content Management System {๐Ÿ“}

What CMS is bmccancer.biomedcentral.com built with?

Custom-built

No common CMS systems were detected on Bmccancer.biomedcentral.com, and no known web development framework was identified.

Traffic Estimate {๐Ÿ“ˆ}

What is the average monthly size of bmccancer.biomedcentral.com audience?

๐Ÿš€ Good Traffic: 50k - 100k visitors per month


Based on our best estimate, this website will receive around 50,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Bmccancer.biomedcentral.com Make Money? {๐Ÿ’ธ}


Display Ads {๐ŸŽฏ}


The website utilizes display ads within its content to generate revenue. Check the next section for further revenue estimates.

Ads are managed by yourbow.com. Particular relationships are as follows:

Direct Advertisers (3)
yourbow.com, google.com, doceree.com

How Much Does Bmccancer.biomedcentral.com Make? {๐Ÿ’ฐ}


Display Ads {๐ŸŽฏ}

$690 per month
Our calculations suggest that Bmccancer.biomedcentral.com earns between $462 and $1,271 monthly online from display advertisements.

Keywords {๐Ÿ”}

ffpe, expression, tissues, profiling, data, cancer, samples, studies, sample, analysis, gene, symposium, clinical, rna, article, bmc, study, quality, assay, archival, tissue, microarray, illumina, nugen, development, simpson, affymetrix, breast, published, amplification, presented, pilot, central, rnaseq, cookies, information, technologies, waldron, challenges, failure, control, large, planning, technical, williams, provided, panel, biostatistics, authors, privacy,

Topics {โœ’๏ธ}

springer nature author information authors ffpe tissue samples abbreviations ct giovanni parmigianiย &ย curtis huttenhower tissue samples archived require additional planning long-term clinical follow dana-farber cancer institute clinical sample failure author correspondence state privacy rights enabled post-hoc identification pre-publication history tissue storage tissue type expression-based diagnostic assay accurate disease classification earliest rt-pcr studies sample failure frequent probe failure long-term health studies formalin-fixed paraffin-embedded gene expression profiling open access article ffpe expression profiles bmc cancer 12 activated b-cell information long-term history rights smaller-scale studies privacy choices/manage cookies ffpe expression studies poor sample quality authors scientific editing ffpe expression data ffpe expression profiling candidate gene panel wg-daslยฎ assay technologies enabling rna-seq housekeeping gene proved breast cancer res archival tissues remain sample characteristics introduced nugen sample preparation patient characterization center clinical ffpe tissues 800-gene panel assayed genome-dasl assay

Schema {๐Ÿ—บ๏ธ}

WebPage:
      mainEntity:
         headline:Report on emerging technologies for translational bioinformatics: a symposium on gene expression profiling for archival tissues
         description:With over 20 million formalin-fixed, paraffin-embedded (FFPE) tissue samples archived each year in the United States alone, archival tissues remain a vast and under-utilized resource in the genomic study of cancer. Technologies have recently been introduced for whole-transcriptome amplification and microarray analysis of degraded mRNA fragments from FFPE samples, and studies of these platforms have only recently begun to enter the published literature. The Emerging Technologies for Translational Bioinformatics symposium on gene expression profiling for archival tissues featured presentations of two large-scale FFPE expression profiling studies (each involving over 1,000 samples), overviews of several smaller studies, and representatives from three leading companies in the field (Illumina, Affymetrix, and NuGEN). The meeting highlighted challenges in the analysis of expression data from archival tissues and strategies being developed to overcome them. In particular, speakers reported higher rates of clinical sample failure (from 10% to 70%) than are typical for fresh-frozen tissues, as well as more frequent probe failure for individual samples. The symposium program is available at http://www.hsph.harvard.edu/ffpe . Multiple solutions now exist for whole-genome expression profiling of FFPE tissues, including both microarray- and sequencing-based platforms. Several studies have reported their successful application, but substantial challenges and risks still exist. Symposium speakers presented novel methodology for analysis of FFPE expression data and suggestions for improving data recovery and quality assessment in pre-analytical stages. Research presentations emphasized the need for careful study design, including the use of pilot studies, replication, and randomization of samples among batches, as well as careful attention to data quality control. Regardless of any limitations in quantitave transcriptomics for FFPE tissues, they are often the only biospecimens available for large patient populations with long-term history and clinical follow-up. Current challenges can be expected to remain as RNA sequencing matures, and they will thus motivate ongoing research efforts into noise reduction and identification of robust, translationally relevant biological signals in expression data from FFPE tissues.
         datePublished:2012-03-29T00:00:00Z
         dateModified:2012-03-29T00:00:00Z
         pageStart:1
         pageEnd:4
         license:https://creativecommons.org/licenses/by/2.0
         sameAs:https://doi.org/10.1186/1471-2407-12-124
         keywords:
            FFPE Tissue
            FFPE Sample
            Archival Tissue
            Sample Failure
            Tissue Gene Expression Profile
            Cancer Research
            Oncology
            Surgical Oncology
            Health Promotion and Disease Prevention
            Biomedicine
            general
            Medicine/Public Health
         image:
         isPartOf:
            name:BMC Cancer
            issn:
               1471-2407
            volumeNumber:12
            type:
               Periodical
               PublicationVolume
         publisher:
            name:BioMed Central
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Levi Waldron
               affiliation:
                     name:Dana-Farber Cancer Institute
                     address:
                        name:Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, USA
                        type:PostalAddress
                     type:Organization
                     name:Harvard School of Public Health
                     address:
                        name:Department of Biostatistics, Harvard School of Public Health, Boston, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Peter Simpson
               affiliation:
                     name:The University of Queensland, UQ Centre for Clinical Research, Herston
                     address:
                        name:The University of Queensland, UQ Centre for Clinical Research, Herston, Brisbane, Australia
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Giovanni Parmigiani
               affiliation:
                     name:Dana-Farber Cancer Institute
                     address:
                        name:Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, USA
                        type:PostalAddress
                     type:Organization
                     name:Harvard School of Public Health
                     address:
                        name:Department of Biostatistics, Harvard School of Public Health, Boston, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Curtis Huttenhower
               affiliation:
                     name:Harvard School of Public Health
                     address:
                        name:Department of Biostatistics, Harvard School of Public Health, Boston, USA
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Report on emerging technologies for translational bioinformatics: a symposium on gene expression profiling for archival tissues
      description:With over 20 million formalin-fixed, paraffin-embedded (FFPE) tissue samples archived each year in the United States alone, archival tissues remain a vast and under-utilized resource in the genomic study of cancer. Technologies have recently been introduced for whole-transcriptome amplification and microarray analysis of degraded mRNA fragments from FFPE samples, and studies of these platforms have only recently begun to enter the published literature. The Emerging Technologies for Translational Bioinformatics symposium on gene expression profiling for archival tissues featured presentations of two large-scale FFPE expression profiling studies (each involving over 1,000 samples), overviews of several smaller studies, and representatives from three leading companies in the field (Illumina, Affymetrix, and NuGEN). The meeting highlighted challenges in the analysis of expression data from archival tissues and strategies being developed to overcome them. In particular, speakers reported higher rates of clinical sample failure (from 10% to 70%) than are typical for fresh-frozen tissues, as well as more frequent probe failure for individual samples. The symposium program is available at http://www.hsph.harvard.edu/ffpe . Multiple solutions now exist for whole-genome expression profiling of FFPE tissues, including both microarray- and sequencing-based platforms. Several studies have reported their successful application, but substantial challenges and risks still exist. Symposium speakers presented novel methodology for analysis of FFPE expression data and suggestions for improving data recovery and quality assessment in pre-analytical stages. Research presentations emphasized the need for careful study design, including the use of pilot studies, replication, and randomization of samples among batches, as well as careful attention to data quality control. Regardless of any limitations in quantitave transcriptomics for FFPE tissues, they are often the only biospecimens available for large patient populations with long-term history and clinical follow-up. Current challenges can be expected to remain as RNA sequencing matures, and they will thus motivate ongoing research efforts into noise reduction and identification of robust, translationally relevant biological signals in expression data from FFPE tissues.
      datePublished:2012-03-29T00:00:00Z
      dateModified:2012-03-29T00:00:00Z
      pageStart:1
      pageEnd:4
      license:https://creativecommons.org/licenses/by/2.0
      sameAs:https://doi.org/10.1186/1471-2407-12-124
      keywords:
         FFPE Tissue
         FFPE Sample
         Archival Tissue
         Sample Failure
         Tissue Gene Expression Profile
         Cancer Research
         Oncology
         Surgical Oncology
         Health Promotion and Disease Prevention
         Biomedicine
         general
         Medicine/Public Health
      image:
      isPartOf:
         name:BMC Cancer
         issn:
            1471-2407
         volumeNumber:12
         type:
            Periodical
            PublicationVolume
      publisher:
         name:BioMed Central
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Levi Waldron
            affiliation:
                  name:Dana-Farber Cancer Institute
                  address:
                     name:Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, USA
                     type:PostalAddress
                  type:Organization
                  name:Harvard School of Public Health
                  address:
                     name:Department of Biostatistics, Harvard School of Public Health, Boston, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Peter Simpson
            affiliation:
                  name:The University of Queensland, UQ Centre for Clinical Research, Herston
                  address:
                     name:The University of Queensland, UQ Centre for Clinical Research, Herston, Brisbane, Australia
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Giovanni Parmigiani
            affiliation:
                  name:Dana-Farber Cancer Institute
                  address:
                     name:Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, USA
                     type:PostalAddress
                  type:Organization
                  name:Harvard School of Public Health
                  address:
                     name:Department of Biostatistics, Harvard School of Public Health, Boston, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Curtis Huttenhower
            affiliation:
                  name:Harvard School of Public Health
                  address:
                     name:Department of Biostatistics, Harvard School of Public Health, Boston, USA
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:BMC Cancer
      issn:
         1471-2407
      volumeNumber:12
Organization:
      name:BioMed Central
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Dana-Farber Cancer Institute
      address:
         name:Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, USA
         type:PostalAddress
      name:Harvard School of Public Health
      address:
         name:Department of Biostatistics, Harvard School of Public Health, Boston, USA
         type:PostalAddress
      name:The University of Queensland, UQ Centre for Clinical Research, Herston
      address:
         name:The University of Queensland, UQ Centre for Clinical Research, Herston, Brisbane, Australia
         type:PostalAddress
      name:Dana-Farber Cancer Institute
      address:
         name:Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, USA
         type:PostalAddress
      name:Harvard School of Public Health
      address:
         name:Department of Biostatistics, Harvard School of Public Health, Boston, USA
         type:PostalAddress
      name:Harvard School of Public Health
      address:
         name:Department of Biostatistics, Harvard School of Public Health, Boston, USA
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Levi Waldron
      affiliation:
            name:Dana-Farber Cancer Institute
            address:
               name:Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, USA
               type:PostalAddress
            type:Organization
            name:Harvard School of Public Health
            address:
               name:Department of Biostatistics, Harvard School of Public Health, Boston, USA
               type:PostalAddress
            type:Organization
      name:Peter Simpson
      affiliation:
            name:The University of Queensland, UQ Centre for Clinical Research, Herston
            address:
               name:The University of Queensland, UQ Centre for Clinical Research, Herston, Brisbane, Australia
               type:PostalAddress
            type:Organization
      name:Giovanni Parmigiani
      affiliation:
            name:Dana-Farber Cancer Institute
            address:
               name:Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, USA
               type:PostalAddress
            type:Organization
            name:Harvard School of Public Health
            address:
               name:Department of Biostatistics, Harvard School of Public Health, Boston, USA
               type:PostalAddress
            type:Organization
      name:Curtis Huttenhower
      affiliation:
            name:Harvard School of Public Health
            address:
               name:Department of Biostatistics, Harvard School of Public Health, Boston, USA
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, USA
      name:Department of Biostatistics, Harvard School of Public Health, Boston, USA
      name:The University of Queensland, UQ Centre for Clinical Research, Herston, Brisbane, Australia
      name:Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, USA
      name:Department of Biostatistics, Harvard School of Public Health, Boston, USA
      name:Department of Biostatistics, Harvard School of Public Health, Boston, USA

External Links {๐Ÿ”—}(50)

Analytics and Tracking {๐Ÿ“Š}

  • Google Tag Manager

Libraries {๐Ÿ“š}

  • Prism.js

CDN Services {๐Ÿ“ฆ}

  • Crossref

3.05s.